← Evidence map

ArticleThe Journal of biological chemistry2015

Interleukin-2-inducible T-cell kinase (ITK) targeting by BMS-509744 does not affect cell viability in T-cell prolymphocytic leukemia (T-PLL).

Sabine Dondorf et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

7 papers cite it

2015

2016

2017

2018

2019

2020

2021

2022

2023

2024

this paperpooled itcites it

Interleukin-2-inducible T-cell kinase (ITK) targeting by BMS-509744 does not affect cell viability in T-cell prolymphocytic leukemia (T-PLL). | OpenQuestion